Related Experiment Video

Updated: Jul 13, 2026

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
10:18

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model

Published on: June 29, 2014

Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects

C Heymes1, A Garnier, S Fuchs

  • 1IFR Circulation, INSERM U527, Hopital Lariboisiere, Université Paris 7, 41 Boulevard de la Chapelle, 75475 Paris cedex 10, France.

Molecular and Cellular Endocrinology
|May 12, 2004
PubMed

Insights

Elevated aldosterone impairs heart function, but cardiac aldosterone synthesis also contributes to heart remodeling. Blocking aldosterone may offer benefits by targeting both systemic and cardiac actions.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Cardiac Pathophysiology

Background:

  • Elevated aldosterone is linked to impaired cardiovascular function and increased mortality.
  • Aldosterone antagonists reduce cardiovascular mortality, but mechanisms are not fully understood.
  • Aldosterone is synthesized in the heart and implicated in cardiac remodeling.

Purpose of the Study:

  • To investigate the role of cardiac aldosterone synthesis in heart function and remodeling.
  • To explore the mechanisms underlying the beneficial effects of aldosterone antagonists.

Main Methods:

  • Investigated aldosterone synthesis in rat hearts.
  • Studied cardiac aldosterone's role in post-infarction remodeling.
  • Utilized transgenic mice overexpressing cardiac aldosterone synthase.
  • Observed cardiac function and coronary function in male and female mice.

Main Results:

  • Cardiac aldosterone synthesis identified in rats and implicated in post-infarction remodeling.
  • Activated cardiac aldosterone production observed in human heart failure.
  • Transgenic mice showed normal cardiac function but significant coronary dysfunction, especially males.
  • Aldosterone antagonists decrease mortality, suggesting blockade of cardiac aldosterone action.

Conclusions:

  • Cardiac aldosterone plays a physiological and pathological role in the heart.
  • Beneficial effects of anti-aldosterone therapy in heart failure may involve blocking cardiac aldosterone.
  • Further research is needed to elucidate the complete role of cardiac aldosterone.

More Related Videos

Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney10:00

Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney

Published on: October 12, 2015

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...